Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | IGF1R | P08069 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 4/20 | 0.34 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24106132 | 0.82 | APP (0.40) | APPTRPV1LMNAIGF1RMTNR1A | |
| SCHEMBL26853199 | 0.79 | BPTF (0.35) | CNR2 | |
| SCHEMBL26853212 | 0.77 | ESR1 (0.38) | LMNA | |
| SCHEMBL25454476 | 0.76 | APP (0.41) | APPTRPV1LMNAIGF1RCNR2 | |
| SCHEMBL26853170 | 0.75 | TRPV1 (0.46) | APPTRPV1LMNA | |
| SCHEMBL26853182 | 0.73 | APP (0.39) | APPTRPV1LMNA | |
| SCHEMBL24106203 | 0.71 | APP (0.44) | APPTRPV1LMNAIGF1R | |
| SCHEMBL26853881 | 0.69 | LMNA (0.36) | LMNACNR2MTNR1AMTNR1B | |
| SCHEMBL26853218 | 0.69 | MEN1 (0.30) | — | |
| SCHEMBL24106130 | 0.68 | APP (0.44) | APPTRPV1LMNAIGF1RMTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11822244-B2 | Compound, resin, resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11822244-B2 | Compound, resin, resist composition and method for producing resist pattern | RER1, AFF1, AFF4 | APP 2604/4885TRPV1 2858/4885LMNA 3320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.